BACKGROUND: The present study examined a cardiac passive restraint device which applies epicardial pressure (HeartNet Implant; Paracor Medical, Inc, Sunnyvale, Calif) in a clinically relevant model of dilated cardiomyopathy to determine effects on hemodynamic and myocardial blood flow patterns. METHODS: Dilated cardiomyopatht was established in 10 pigs (3 weeks of atrial pacing, 240 beats/min). Hemodynamic parameters and regional left ventricular blood flow were measured under baseline conditions and after acute placement of the HeartNet Implant. Measurements were repeated after adenosine infusion, allowing maximal coronary vasodilation and coronary flow reserve to be determined. RESULTS: Left ventricular dilation and systolic dysfunction occurred relative to baseline as measured by echocardiography. Left ventricular end-diastolic dimension increased and left ventricular fractional shortening decreased (3.8 ± 0.1 vs 6.1 ± 0.2 cm and 31.6% ± 0.5% vs 16.2% ± 2.1%, both P < .05, respectively), consistent with the dilated cardiomyopathy phenotype. The HeartNet Implant was successfully deployed without arrhythmias and a computed median mid-left ventricular epicardial pressure of 1.4 mm Hg was applied by the HeartNet Implant throughout the cardiac cycle. Acute HeartNet placement did not adversely affect steady state hemodynamics. With the HeartNet Implant in place, coronary reserve was significantly blunted. CONCLUSIONS: In a large animal model of dilated cardiomyopathy, the cardiac passive restraint device did not appear to adversely affect basal resting myocardial blood flow. However, after acute HeartNet Implant placement, left ventricular maximal coronary reserve was blunted. These unique results suggest that cardiac passive restraint devices that apply epicardial transmural pressure can alter myocardial blood flow patterns in a model of dilated cardiomyopathy. Whether this blunting of coronary reserve holds clinical relevance with chronic passive restraint device placement remains unestablished.
BACKGROUND: The present study examined a cardiac passive restraint device which applies epicardial pressure (HeartNet Implant; Paracor Medical, Inc, Sunnyvale, Calif) in a clinically relevant model of dilated cardiomyopathy to determine effects on hemodynamic and myocardial blood flow patterns. METHODS:Dilated cardiomyopatht was established in 10 pigs (3 weeks of atrial pacing, 240 beats/min). Hemodynamic parameters and regional left ventricular blood flow were measured under baseline conditions and after acute placement of the HeartNet Implant. Measurements were repeated after adenosine infusion, allowing maximal coronary vasodilation and coronary flow reserve to be determined. RESULTS:Left ventricular dilation and systolic dysfunction occurred relative to baseline as measured by echocardiography. Left ventricular end-diastolic dimension increased and left ventricular fractional shortening decreased (3.8 ± 0.1 vs 6.1 ± 0.2 cm and 31.6% ± 0.5% vs 16.2% ± 2.1%, both P < .05, respectively), consistent with the dilated cardiomyopathy phenotype. The HeartNet Implant was successfully deployed without arrhythmias and a computed median mid-left ventricular epicardial pressure of 1.4 mm Hg was applied by the HeartNet Implant throughout the cardiac cycle. Acute HeartNet placement did not adversely affect steady state hemodynamics. With the HeartNet Implant in place, coronary reserve was significantly blunted. CONCLUSIONS: In a large animal model of dilated cardiomyopathy, the cardiac passive restraint device did not appear to adversely affect basal resting myocardial blood flow. However, after acute HeartNet Implant placement, left ventricular maximal coronary reserve was blunted. These unique results suggest that cardiac passive restraint devices that apply epicardial transmural pressure can alter myocardial blood flow patterns in a model of dilated cardiomyopathy. Whether this blunting of coronary reserve holds clinical relevance with chronic passive restraint device placement remains unestablished.
Authors: S Schenk; H Reichenspurner; J G. Groezner; D H. Boehm; J Schirmer; W V. Scheidt; B Reichart Journal: J Heart Lung Transplant Date: 2001-02 Impact factor: 10.247
Authors: Aaron S Blom; Rupak Mukherjee; James J Pilla; Abigail S Lowry; William M Yarbrough; Joseph T Mingoia; Jennifer W Hendrick; Robert E Stroud; Julie E McLean; John Affuso; Robert C Gorman; Joseph H Gorman; Michael A Acker; Francis G Spinale Journal: Circulation Date: 2005-08-30 Impact factor: 29.690
Authors: Douglas L Mann; Michael A Acker; Mariell Jessup; Hani N Sabbah; Randall C Starling; Spencer H Kubo Journal: Ann Thorac Surg Date: 2007-10 Impact factor: 4.330
Authors: R S Krombach; M J Clair; J W Hendrick; W V Houck; J L Zellner; S B Kribbs; S Whitebread; R Mukherjee; M de Gasparo; F G Spinale Journal: Cardiovasc Res Date: 1998-06 Impact factor: 10.787
Authors: James A Magovern; Leah Teekell-Taylor; Sunil Mankad; Uday Dasika; Walter McGregor; Robert W W Biederman; June Yamrozik; Dennis R Trumble Journal: ASAIO J Date: 2006 Mar-Apr Impact factor: 2.872
Authors: Lawrence S Lee; Ravi K Ghanta; Suyog A Mokashi; Otavio Coelho-Filho; Raymond Y Kwong; Michael Kwon; Jian Guan; Ronglih Liao; Frederick Y Chen Journal: J Thorac Cardiovasc Surg Date: 2012-06-12 Impact factor: 5.209
Authors: Sam Chitsaz; Jonathan F Wenk; Liang Ge; Andrew Wisneski; Aart Mookhoek; Mark B Ratcliffe; Julius M Guccione; Elaine E Tseng Journal: Ann Thorac Surg Date: 2012-09-13 Impact factor: 4.330